Announcements Trials
Browse Landscape

Phase

Phase 2 14Phase 1 6Phase 1/2 4Phase NA 3Phase EARLY_PHASE1 2Phase 4 2Phase 3 2

Status

Completed 5Unknown 2

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2

Conditions

Recurrence 2Leukemia, Myeloid, Acute 1Leukemia 1

Interventions

Metformin 16Cyclophosphamide 16Drug Therapy 14Dexamethasone 14Cisplatin 13Cytarabine 11Gemcitabine 10Radiotherapy 9Oxaliplatin 9Carboplatin 9Vincristine 8Paclitaxel 8Idarubicin 8Etoposide 8Docetaxel 8ulipristal acetate 7icotinib 7Sodium Chloride 7Methotrexate 7Fluorouracil 7Dexmedetomidine 7entecavir 6Thalidomide 6Surgical Procedures, Operative 6Sorafenib 6Pemetrexed 6Leuprolide 6Granulocyte Colony-Stimulating Factor 6Epirubicin 6Doxorubicin 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 4 × Unknown × fludarabine phosphate × Clear all
NCT02784561 2016-05-27

Study of Busulfan and FLAG Conditioning Regimen for Allogeneic Peripheral Blood Stem Cell Transplantation

Chinese PLA General Hospital

Phase 4 Unknown
80 enrolled
Other hematologic neoplasm

Leukemia, Recurrence

NCT02024308 2013-12-31

AML1-ETO Acute Myeloid Leukemia With Fludarabine and Cytarabine Chemotherapy

Changhai Hospital

Phase 4 Unknown
62 enrolled
Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡